TICKERNERD
Menu
XRAYXRAYHealthcare · Medical Instruments & Supplies

XRAY Stock Forecast: Dentsply Sirona, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$14
+5.68% on the day

The 18 Wall Street analysts covering Dentsply Sirona, Inc. hold a median 12-month price target of $14 — -0.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 87 of 100 as at 1 Aug 2026 — inside the top quartile. The factors read stronger than the Street's target implies. That gap is the story on this page.

Market cap
$2.7B
Ticker Nerd rank
87 / 100
Median analyst target
$14
Analysts covering
18
Total return, dividends reinvested
1W
+8.5%
1M
+21.3%
YTD
+23.6%
1Y
+1.3%
From 52W high
−3.7%
From 52W low
+46.6%
$10
$15
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

XRAY stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Dentsply Sirona, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
87 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
96
Accruals
91
Issuance
89
Volatility
84
Growth
73
Quality
54
Revisions
49
Momentum
43
Size
32

Value (96): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (43): The shares have been drifting down relative to others.

Size (32): Larger than most of the companies we track — more scrutinised, less often mispriced.

The rank is the raw material. Whether the rules would actually own Dentsply Sirona, Inc. — and when they’d sell — is the membership.

Wall Street

XRAY stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on XRAY, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$8$10$12$14$16$18Oct 25Jan 26Apr 26Jul 26XRAYHigh $17Median $14Low $9

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says18 analysts
3 Buy13 Hold2 Sell
Low $9Median $14High $17

The green dot is the last close — the median target sits −0.9% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
29 July 2026Piper SandlerMaintainsNeutral$13 → $14
9 July 2026BMO CapitalInitiatesMarket Perform$12
4 June 2026BarclaysMaintainsUnderweight—
7 May 2026UBSMaintainsBuy—
6 May 2026MizuhoMaintainsNeutral—
15 Apr 2026CitigroupInitiatesSell—
2 Mar 2026Barrington ResearchMaintainsOutperform—
2 Mar 2026MizuhoMaintainsNeutral—
27 Feb 2026BairdMaintainsNeutral—
27 Feb 2026Evercore ISI GroupMaintainsIn-Line—
27 Feb 2026Wells FargoMaintainsEqual-Weight—
19 Feb 2026B of A SecuritiesUpgradeBuy—
3 Feb 2026UBSMaintainsBuy—
20 Jan 2026MizuhoMaintainsNeutral—
5 Jan 2026Barrington ResearchMaintainsOutperform—
16 Dec 2025BairdMaintainsNeutral—
16 Dec 2025Barrington ResearchMaintainsOutperform—
9 Dec 2025BarclaysInitiatesUnderweight—
10 Nov 2025Barrington ResearchMaintainsOutperform—
7 Nov 2025JP MorganMaintainsNeutral—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

XRAY analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−0.7%
Analysts raising
2
Analysts cutting
7
Fundamentals

Dentsply Sirona, Inc. (XRAY) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−4.5×

Cheaper than 89% of US stocks

Price / sales
0.7×

Cheaper than 76% of US stocks

Price / book
2.0×

Cheaper than 46% of US stocks

EV / EBITDA
8.7×

Cheaper than 43% of US stocks

Growth & margins
Revenue growth (YoY)
0.1%

Higher than 29% of US stocks

Earnings growth (YoY)
0.1%

Higher than 36% of US stocks

Gross margin
48.5%

Higher than 62% of US stocks

Operating margin
3.4%

Higher than 54% of US stocks

Net margin
−17.1%

Higher than 16% of US stocks

Returns & dividend
Return on equity
−37.7%

Higher than 24% of US stocks

Return on assets
2.3%

Higher than 61% of US stocks

Dividend yield
4.8%

Higher than 82% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

XRAY vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
XRAYDentsply Sirona, Inc.$2.7B
87
PLSEPulse Biosciences, Inc.$2.4B
45
LMATLeMaitre Vascular, Inc.$2.3B
91
WRBYWarby Parker, Inc.$3.2B
34
ATRCAtriCure, Inc.$1.9B
91
ICUIICU Medical, Inc.$4.2B
93
NVSTEnvista Holdings Corp.$4.5B
97
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. XRAY appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest XRAY news & analysis

Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire · 29 July 2026negative

A law firm is reaching out to Dentsply Sirona shareholders regarding potential breaches of fiduciary duties by the company's insiders, offering no-cost consultations and contingent-fee representation.

Why it matters — XRAY watchers would care because the investigation raises questions about whether company insiders violated their obligations to shareholders, which could lead to legal or governance repercussions.

Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship

GlobeNewsWire · 28 July 2026positive

Dentsply Sirona announced it is expanding its long-standing relationship with Medline Sinclair, a full-service dental distributor in Canada, to advance its commercial growth strategy.

Why it matters — The expanded partnership with a leading Canadian distributor signals Dentsply Sirona's continued focus on strengthening its commercial presence in the Canadian dental market.

FAQ

Frequently asked questions about XRAY stock

What is the XRAY stock price forecast for 2026-2027?

The 18 Wall Street analysts covering Dentsply Sirona, Inc. have a median 12-month price target of $14, with estimates ranging from $9 to $17. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is XRAY stock a buy right now?

Of the 18 analysts covering Dentsply Sirona, Inc., 3 rate it a Buy, 13 a Hold and 2 a Sell. Ticker Nerd's systematic factor model ranks Dentsply Sirona, Inc. 87 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank XRAY?

As at 1 Aug 2026, Dentsply Sirona, Inc. ranks 87 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (96 of 100).

Will XRAY stock go up?

No one can know that. What the data says: the median 12-month target from 18 analysts implies -0.9% from the last close, and Ticker Nerd's factor model ranks Dentsply Sirona, Inc. 87 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the XRAY stock forecast for 2030?

No analyst covering Dentsply Sirona, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for XRAY are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $9 to $17 over the next 12 months.

How has XRAY stock performed over the past year?

Dentsply Sirona, Inc. returned +1.3% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Dentsply Sirona, Inc. do?

Dentsply Sirona Inc. develops, manufactures, and markets professional dental products and technologies worldwide.

What is the latest news on XRAY?

The most recent item we track (PRNewsWire, 29 July 2026): "Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?". A law firm is reaching out to Dentsply Sirona shareholders regarding potential breaches of fiduciary duties by the company's insiders, offering no-cost consultations and contingent-fee representation.

Company

About Dentsply Sirona, Inc.

Dentsply Sirona Inc. develops, manufactures, and markets professional dental products and technologies worldwide. It specializes in dental equipment supported by cloud-enabled solutions, alongside dental consumables and healthcare products for urology and enterology. The company operates through four key segments: Connected Technology Solutions, which provides imaging equipment, motorized handpieces, treatment centers, intraoral scanners, 3D printers, and mills like CEREC for chairside restorations; Essential Dental Solutions, offering endodontic, restorative, and preventive consumables; Orthodontic and Implant Solutions, featuring digital implant systems and orthodontic products; and Wellspect Healthcare, delivering continence care solutions for urinary and bowel management. These offerings serve dental professionals, orthodontists, oral surgeons, and healthcare providers, enhancing diagnostics, treatments, and patient care in dentistry and related fields. Founded in 1899 and headquartered in Charlotte, North Carolina, Dentsply Sirona Inc. plays a vital role in advancing oral health technologies and specialized medical consumables.

CEO Mr. Daniel T. Scavilla · 14,000 employees · United States · https://www.dentsplysirona.com